Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin section
- 1 March 1990
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 160 (3) , 239-243
- https://doi.org/10.1002/path.1711600310
Abstract
The leukocyte antigen CD23 is expressed during B‐cell development, and functions as an IgE receptor and a lymphocyte growth factor. We studied the expression of CD23 in paraffin sections of lymphoid tissue using the monoclonal antibody BU38. Fifteen cases of Hodgkin's disease, ten reactive lymph nodes, eight B‐cell, and seven T‐cell non‐Hodgkin's lymphomas were analysed immunohistologically. CD23 positivity was seen on follicular dendritic cells and a small number of lymphocytes in reactive nodes. Thirteen of the 15 cases of Hodgkin's disease showed CD23 expression in both neoplastic cells and reactive lymphocytic infiltrate. The antigen was demonstrated in four of the B‐cell of the T‐cell tumours. CD23 may be important in mediating she mixed cellular infiltrate characteristic of Hodgkin's lymphoma.Keywords
This publication has 24 references indexed in Scilit:
- CD23: a multi-functional receptor/ lymphokine?Immunology Today, 1989
- Hodgkin's Disease and Epstein-Barr VirusNew England Journal of Medicine, 1989
- The Elusive Reed–Sternberg CellNew England Journal of Medicine, 1989
- Detection of Epstein–Barr Viral Genomes in Reed–Sternberg Cells of Hodgkin's DiseaseNew England Journal of Medicine, 1989
- Two species of human Fcε receptor II ( ): Tissue-specific and IL-4-specific regulation of gene expressionCell, 1988
- Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphomaThe Journal of Pathology, 1988
- The molecules controlling B lymphocytesImmunology Today, 1987
- Molecular structure of human lymphocyte receptor for immunoglobulin ECell, 1986
- Ligation of the CD23, p45 (BLAST‐2, EBVCS) antigen triggers the cell‐cycle progression of activated B lymphocytesEuropean Journal of Immunology, 1986